Insurance Status Is Related to Receipt of Therapy and Survival in Patients with Early-Stage Pancreatic Exocrine Carcinoma

by Emily Boevers, Bradley D. McDowell, Sarah L. Mott, Anna M. Button, Charles F. Lynch
Published 2017-01-01

Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells

by Jennifer E. Hrabe, Brianne R. O’Leary, Melissa A. Fath, Samuel N. Rodman, Anna M. Button, Frederick E. Domann, Douglas R. Spitz, James J. Mezhir
Published 2015-08-01